Bone scintigraphy reduces the need for biopsy in suspected cardiac amyloidosis
Tidsskr Nor Laegeforen. 2023 Jun 12;143(9).
doi: 10.4045/tidsskr.22.0644.
Print 2023 Jun 13.
[Article in
English,
Norwegian]
No abstract available
Plain language summary
The gold standard to diagnose suspected cardiac amyloidosis is myocardial biopsy. In recent years, bone scintigraphy has partly replaced myocardial biopsy.
MeSH terms
-
Biopsy*
-
Humans
-
Radionuclide Imaging